Australia - engleză - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - tenofovir disoproxil fumarate, quantity: 300 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; triacetin - viread in combination with other antiretroviral agents is indicated for the treatment of hiv-infected adults and paediatric patients 12 years of age and older.,viread is indicated for the treatment of chronic hepatitis b in adults (see clinical trials).,viread is indicated for the treatment of chronic hepatitis b in paediatric patients 12 years of age and older with compensated liver disease and with evidence of immune active disease, i.e. active viral replication, persistently elevated serum alt levels or evidence of active inflammation. viread in combination with other antiretroviral agents is indicated for the treatment of hiv-infected adults. viread is indicated for the treatment of chronic hepatitis b in adults with evidence of active viral replication and active liver inflammation.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - gabapentin, quantity: 300 mg - capsule - excipient ingredients: lactose monohydrate; maize starch; purified talc; gelatin; purified water; sodium lauryl sulfate; titanium dioxide; iron oxide yellow - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. gabapentin is indicated for the treatment of neuropathic pain.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 300 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; brilliant blue fcf; sunset yellow fcf; purified water; allura red ac; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - pregabalin, quantity: 300 mg - capsule - excipient ingredients: purified talc; maize starch; pregelatinised maize starch; titanium dioxide; brilliant blue fcf; sunset yellow fcf; purified water; allura red ac; gelatin; sodium lauryl sulfate - cipla pregabalin (pregabalin) is indicated for the treatment of neuropathic pain in adults. cipla pregabalin (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Iordania - engleză - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع خوري - khoury drug store - gabapentin 300 mg - 300 mg

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

viatris limited - gabapentin 300mg - capsule - 300 mg - active: gabapentin 300mg excipient: allura red ac gelatin lactose monohydrate maize starch purified talc quinoline yellow titanium dioxide - treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard antiepileptic drugs.

Singapore - engleză - HSA (Health Sciences Authority)

dch auriga singapore - iomeprol eqv iodine - injection - 300 mg/ml - iomeprol eqv iodine 300 mg/ml

Australia - engleză - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - quetiapine fumarate, quantity: 345.36 mg (equivalent: quetiapine, qty 300 mg) - tablet, film coated - excipient ingredients: magnesium stearate; calcium hydrogen phosphate dihydrate; lactose monohydrate; microcrystalline cellulose; sodium starch glycollate type a; hypromellose; titanium dioxide; macrogol 400; povidone - bipolar disorder, adults maintenance treatment of bipolar i disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes, treatment of depressive episodes associated with bipolar disorder (see dosage and administration), treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate, children/adolescents aged 10 to 17 years, monotherapy treatment of acute mania associated with bipolar i disorder, schizophrenia (adults and adolescents aged 13 to 17 years), treatment of schizophrenia

Australia - engleză - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; silicon dioxide; croscarmellose sodium; hypromellose; carnauba wax; magnesium stearate; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 3000 - avapro hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - moclobemide, quantity: 300 mg - tablet, film coated - excipient ingredients: maize starch; magnesium stearate; macrogol 6000; titanium dioxide; lactose monohydrate; sodium starch glycollate; hypromellose; povidone; purified talc; purified water; ethylcellulose; cetyl alcohol; hydrogen peroxide; sodium lauryl sulfate; octamethylcyclotetrasiloxane; silica dimethicone silylate; dimeticone 5000; cyclomethicone - treatment of major depression.